Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Avastin and Pelvic Radiation for Recurrent Gynecological Cancers
NCT00545792Phase 2Completed
- Sponsor
- Dana-Farber Cancer Institute
- Start
- May 2007
- Primary completion
- Nov 2010
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of bevacizumab in Cervical Cancer (CC), endometrial cancer (EC), ovarian cancer, vaginal cancer, vulvar cancer, sponsored by Dana-Farber Cancer Institute. Started May 2007; status: completed.
02
Drugs
bevacizumab
03
Conditions
Cervical Cancer (CC)endometrial cancer (EC)ovarian cancervaginal cancervulvar cancer
Beyond the preview
Go deeper on NCT00545792.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00545792.